1.
The march toward malaria vaccines
by Hoffman, Stephen L
Vaccine, 2015, Vol.33 (Suppl 4), p.D13-D23
2.
Transmission blocking malaria vaccines: Assays and candidates in clinical development
by Sauerwein, R.W
Vaccine, 2015, Vol.33 (52), p.7476-7482
3.
Designing malaria vaccines to circumvent antigen variability
by Ouattara, Amed
Vaccine, 2015, Vol.33 (52), p.7506-7512
4.
Quantitative imaging of Plasmodium transmission from mosquito to mammal
by Amino, Rogerio
Nature Medicine, 2006, Vol.12 (2), p.220-224
5.
Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria
by Schofield, Louis
Nature (London), 2002, Vol.418 (6899), p.785-789
6.
Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model
by Dunachie, Susanna
Vaccine, 2015, Vol.33 (40), p.5321-5331
7.
Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates
by Annoura, Takeshi
Vaccine, 2012, Vol.30 (16), p.2662-2670
8.
Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research
by Good, Michael F
Annual review of immunology, 2005, Vol.23 (1), p.69-99
9.
Profiling the host response to malaria vaccination and malaria challenge
by Dunachie, Susanna
Vaccine, 2015, Vol.33 (40), p.5316-5320
10.
Malaria vaccine developments
by Moorthy, Vasee S
The Lancet (British edition), 2004, Vol.363 (9403), p.150-156
11.
Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial
by Hermsen, Cornelus C
Vaccine, 2007, Vol.25 (15), p.2930-2940
12.
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
by White, Michael T, Dr
The Lancet infectious diseases, 2015, Vol.15 (12), p.1450-1458
13.
Immune mechanisms in malaria: new insights in vaccine development
by Riley, Eleanor M
Nature medicine, 2013, Vol.19 (2), p.168-178
14.
Development of vaccines for Plasmodium vivax malaria
by Mueller, Ivo
Vaccine, 2015, Vol.33 (52), p.7489-7495
15.
Whole organism blood stage vaccines against malaria
by Stanisic, Danielle I
Vaccine, 2015, Vol.33 (52), p.7469-7475
17.
Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs
by Murugan, Rajagopal
Nature medicine, 2020, Vol.26 (7), p.1135-1145
18.
Novel approaches to whole sporozoite vaccination against malaria
by Bijker, Else M
Vaccine, 2015, Vol.33 (52), p.7462-7468
19.
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine
by Kappe, Stefan H. I
Nature, 2005, Vol.433 (7022), p.164-167
20.
Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region
by Anyona, Samuel B.
Journal of human genetics, 2019, Vol.65 (2), p.99-113
